CVCA H1 Quarterly Exclusive: PE & VC Review

    CVCA H1 Quarterly Exclusive: PE & VC Review

These articles have been a part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. The series provides an analysis

Read Full Article

CVCA H1 Quarterly Exclusive: Top VC Deal Profile – Repare Therapeutics Inc.

    CVCA H1 Quarterly Exclusive: Top VC Deal Profile – Repare Therapeutics Inc.

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s

Read Full Article

Inception IBD Completes Series A Financing

    Inception IBD Completes Series A Financing

Inception IBD has announced the completion of a $14.1 million Series A financing led by Versant Ventures and joined by Fonds de solidarité FTQ, along with existing investor Inserm Transfert

Read Full Article

Northleaf first VCAP fund to reach max fund size at $300M

    Northleaf first VCAP fund to reach max fund size at $300M

Northleaf Capital Partners, Canada’s largest independent global private markets fund manager, has announced that Northleaf Venture Catalyst Fund (NVCF) has

Read Full Article

Northleaf Venture Catalyst Fund completes another close with total commitments of $264M

    Northleaf Venture Catalyst Fund completes another close with total commitments of $264M

Northleaf Capital Partners, Canada’s largest independent global private markets fund manager, has announced that Northleaf Venture Catalyst Fund (NVCF) recently

Read Full Article

Northern Biologics and Celgene enter strategic collaboration

    Northern Biologics and Celgene enter strategic collaboration

Northern Biologics Inc., a privately held biotechnology company, announced an exclusive, strategic collaboration with Celgene Corporation. As part of the

Read Full Article

Versant Venture Capital V final closes at $305M

    Versant Venture Capital V final closes at $305M

Versant Ventures, has closed Versant Venture Capital V L.P. at US $305 million, exceeding its target size of $250 million,

Read Full Article

Northleaf Venture Catalyst Fund holds second closing

Northleaf Capital Partners has recently held a second close for Northleaf Venture Catalyst Fund (NVCF), the first fund of funds

Read Full Article

Versant Ventures secures Canadian commitments

Versant Venture Management, LLC has held a close with Canadian commitment for Versant Venture Capital V, L.P., from Teralys Capital,

Read Full Article

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter